ArticleCancer immunology, immunotherapy : CII2018

Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy.

Tímea Balatoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.